425 related articles for article (PubMed ID: 36154605)
1. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
[TBL] [Abstract][Full Text] [Related]
2. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
4. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.
Wasim R; Mahmood T; Siddiqui MH; Ahsan F; Shamim A; Singh A; Shariq M; Parveen S
Life Sci; 2022 Oct; 307():120860. PubMed ID: 35940220
[TBL] [Abstract][Full Text] [Related]
5. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
6. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
7. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
Kinscherf NA; Pehar M
Curr Drug Targets; 2022; 23(12):1191-1209. PubMed ID: 35702767
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.
Chrysanthou M; Miro Estruch I; Rietjens IMCM; Wichers HJ; Hoppenbrouwers T
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057544
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.
Yamagishi S; Fukami K; Matsui T
Cardiovasc Diabetol; 2015 Jan; 14():2. PubMed ID: 25582643
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.
Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B
Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234
[TBL] [Abstract][Full Text] [Related]
12. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
[TBL] [Abstract][Full Text] [Related]
13. AGE-RAGE synergy influences programmed cell death signaling to promote cancer.
Waghela BN; Vaidya FU; Ranjan K; Chhipa AS; Tiwari BS; Pathak C
Mol Cell Biochem; 2021 Feb; 476(2):585-598. PubMed ID: 33025314
[TBL] [Abstract][Full Text] [Related]
14. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
16. Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment.
Singh A; Ansari VA; Mahmood T; Ahsan F; Wasim R; Shariq M; Parveen S; Maheshwari S
Drug Res (Stuttg); 2023 Jun; 73(5):247-250. PubMed ID: 36889338
[TBL] [Abstract][Full Text] [Related]
17. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease.
Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ
ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651
[TBL] [Abstract][Full Text] [Related]
18. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
19. The RAGE signaling in osteoporosis.
Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M
Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815
[TBL] [Abstract][Full Text] [Related]
20. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]